Individual Cognitive Stimulation Therapy for dementia (iCST): study protocol for a randomized controlled trial

Martin Orrell, Lauren A Yates, Alistair Burns, Ian Russell, Robert T Woods, Zoe Hoare, Esme Moniz-Cook, Catherine Henderson, Martin Knapp, Aimee Spector, Vasiliki Orgeta, Martin Orrell, Lauren A Yates, Alistair Burns, Ian Russell, Robert T Woods, Zoe Hoare, Esme Moniz-Cook, Catherine Henderson, Martin Knapp, Aimee Spector, Vasiliki Orgeta

Abstract

Background: Improving the quality of care for people with dementia and their carers has become a national priority in many countries. Cognitive Stimulation Therapy (CST) groups can be beneficial in improving cognition and quality of life for people with dementia. The aim of the current study is to develop and evaluate a home-based individual Cognitive Stimulation Therapy (iCST) programme for people with dementia which can be delivered by their family carer.

Methods: This multi-centre, pragmatic randomised controlled trial (RCT) will compare the effectiveness and cost-effectiveness of iCST for people with dementia with a treatment as usual control group. The intervention consists of iCST sessions delivered by a carer for 30 minutes, 3 times a week over 25 weeks.For people with dementia the primary outcome measures are cognition assessed by the ADAS-Cog, and quality of life assessed by QoL-AD. For carers, quality of life using the SF-12 is the primary outcome measure. Using a 5% significance level, comparison of 306 participants will yield 80% power to detect an effect size of 0.35 for cognition as measured by the ADAS-Cog, and quality of life as measured by the QoL-AD. Quality of life for the carer will be measured using the SF-12. The trial will include a cost-effectiveness analysis from a public sector perspective.

Discussion: The UK Department of Health has recently stressed that improving access to psychological therapies is a national priority, but many people with dementia are unable to access psychological interventions. The development of a home-based individual version of CST will provide an easy to use, widely available therapy package that will be evaluated for effectiveness and cost-effectiveness in a multi centre RCT.

Figures

Figure 1
Figure 1
Flow of participants through the iCST randomised controlled trial.

References

    1. National Dementia Strategy. .
    1. Knapp M, Prince M, Albanese E, Banerjee S, Dhanasiri S, Fernandez JL, Ferri C, McCrone P, Snell T, Stewart R. Dementia UK a report into the prevalence and cost of dementia prepared by the Personal social Services Research Unit (PCSSRU) at the London School of Economics and Institute of Psychiatry at King’s College London for the Alzheimer’s Society. London: Alzheimer’s Society; 2007.
    1. Department of Health: National service framework for older people. 2001. [ ]
    1. Spector A, Davies S, Woods B, Orrell M OM. Reality Orientation for Dementia: A Systematic Review of the Evidence of Effectiveness from Randomized Controlled Trials. Gerontologist. 2000;40:206–212. doi: 10.1093/geront/40.2.206.
    1. Spector A, Thorgrimsen L, Woods B, Royan L, Davies S, Butterworth M, Orrell M. A randomised control trial investigating the effectiveness of an evidence-based cognitive stimulation therapy programme for people with dementia. Br J Psychiatry. 2003;183:248–254. doi: 10.1192/bjp.183.3.248.
    1. Knapp M, Thorgrimsen L, Patel A, Spector A, Hallam A, Woods B, Orrell M. Cognitive Stimulation Therapy for dementia: is it cost effective? Br J Psychiatry. 2006;188:574–580. doi: 10.1192/bjp.bp.105.010561.
    1. National Institute for Health and Clinical Excellence and the Social Care Institute for Excellence (NICE-SCIE) Dementia: supporting people with dementia and their carers in health and social care. London: NICE-SCIE: Clinical Guideline 42; 2006.
    1. Orrell M, Spector A, Thorgrimsen L, Woods B. A pilot study examining the effectiveness of maintenance Cognitive Stimulation Therapy (MCST) for people with dementia. Int J Geriatr Psychiatry. 2005;20:446–451. doi: 10.1002/gps.1304.
    1. Olazaran J, Muniz R, Reisberg B, Peña-Casanova J, del Ser T, Cruz-Jentoft AJ, Serrano P, Navarro E, Garcia de la Rocha ML, Frank A, Galiano M, Fernández Bullido Y, Serra JA, González-Salvador MT, Sevilla C. Benefits of cognitive-motor intervention in MCI and mild to moderate Alzheimer's disease. Neurology. 2004;63:2348–2353. doi: 10.1212/01.WNL.0000147478.03911.28.
    1. Aguirre E, Spector A, Hoe J, Russell IT, Knapp M, Woods RT, Orrell M. Maintenance Cognitive Stimulation Therapy (CST) for dementia: A single blind, multi-centre, randomized controlled trial of maintenance CST vs.CST for dementia. Trials. 2010;11:46. doi: 10.1186/1745-6215-11-46.
    1. Moniz-Cook E, Agar S, Gibson G, Win T, Wang M. A preliminary study of the effects of early intervention with people with dementia and their families in a memory clinic. Aging & Mental Health. 1998;2:199–211. doi: 10.1080/13607869856687.
    1. Quayhagen MP, Quayhagen M, Corbeil RR, Hendrix RC, Jackson JE, Snyder L, Bower D. Coping with dementia: Evaluation of four non pharmacological interventions. Int Psychogeriatr. 2000;12:249–266. doi: 10.1017/S1041610200006360.
    1. Quayhagen MP, Quayhagen M. Testing of a cognitive stimulation intervention for dementia caregiving dyads. Neuropsychological Rehabilitation. 2000;11:319–332.
    1. Onder G, Zanetti O, Giacobini E, Frisoni GB, Bartorelli L, Carbone G, Lambertucci P, Silveri MC, Bernabei R. Reality orientation therapy combined with cholinesterase inhibitors in Alzheimer’s disease: randomised controlled trial. Br J Psychiatry. 2005;187:450–455. doi: 10.1192/bjp.187.5.450.
    1. Woods B, Aguirre E, Spector AE, Orrell M. Cognitive stimulation to improve cognitive functioning in people with dementia. Cochrane Database Syst Rev. 2012;2:005562. doi: 10.1002/14651858.CD005562.pub2.
    1. Orrell M, Hancock GA, Galboda Liyanage KC, Woods B, Challis D, Hoe J. The needs of people with dementia in care homes: the perspectives of users, staff and family caregivers. Int Psychogeriatr. 2008;20:941–951.
    1. Wenborn J, Challis D, Orrell M. PhD thesis. University College London, Department of Mental Health Sciences; 2010. Does an occupational therapy intervention for older people with dementia in care homes improve quality of life? A cluster randomized control trial.
    1. Office of Public Sector Information (OPSI) Mental Capacity Act. .
    1. Russell D, Hoare ZSJ, Whitaker R, Whitaker CJ, Russell IT. Generalized method for adaptive randomization in clinical trials. Stat Med. 2011;30:922–934. doi: 10.1002/sim.4175.
    1. Medical Research Council. Developing and evaluating complex interventions – new guidance. 2008. .
    1. Jones J, Hunter D. Consensus methods for medical and health services research. BMJ. 1995;311:376–380. doi: 10.1136/bmj.311.7001.376.
    1. Burgio L, Lichstein KL, Nichols L, Czaja S, Gallagher-Thompson D. Judging outcomes in psychosocial interventions for dementia caregivers: the problem of treatment implementation. Gerontologist. 2001;41:481–489. doi: 10.1093/geront/41.4.481.
    1. Lichstein KI, Riedel BW, Grieve R. Fair tests of clinical trials: A treatment implementation model. Advances in Behaviour Research and Therapy. 1994;16:1–29. doi: 10.1016/0146-6402(94)90001-9.
    1. Beecham J, Knapp M. In: Measuring mental health needs. Thornicroft G, Brewin C, Wing J, editor. London: Gaskell; 1992. Costing psychiatric interventions; pp. 163–183.
    1. Rosen WG, Mohs RC, Davis KL. A new rating scale for Alzheimer’s disease. Am J Psychiatry. 1984;141:1356–1364.
    1. Weyer G, Erzigkeit H, Kanowski S, Ihl R, Hadler D. Alzheimer’s Disease Assessment Scale: reliability and validity in a multicenter clinical trial. Int Psychogeriatr. 1997;9:123–138.
    1. Logsdon RG, Gibbons LE, McCurry SM, Teri L. Assessing quality of life in older adults with cognitive impairment. Psychosom Med. 2002;64:510–519.
    1. Moniz-Cook E, Vernooij-Dassen M, Woods R, Verhey F, Chattat R, de Vugt M, Mountain G, O’Connell M, Harrison J, Vasse E, Dröes RM, Orrell M. A European consensus on outcome measures for psychosocial intervention research in dementia care. Aging Ment Health. 2008;12:14–25. doi: 10.1080/13607860801919850.
    1. Smith SC, Lamping DL, Banerjee S, Harwood A, Foley B, Smith P, Cook JC, Murray J, Prince M, Levin E, Mann A, Knapp M. Measurement of health-related quality of life for people with dementia: development of a new instrument (DEMQOL) and an evaluation of current methodology. Health Technology Assessment. 2005;9:1112.
    1. Thorgrimsen L, Selwood A. Spector A, de Madariaga Lopez M, Woods RT, Orrell M: Whose quality of life is it anyway? The validity and reliability of the Quality of Life-Alzheimer’s Disease (QOL-AD) Scale. Alzheimer Dis Assoc Disord. 2003;17:201–208. doi: 10.1097/00002093-200310000-00002.
    1. Mulhern B, Rowen D, Brazier J, Smith SC, Romeo R, Tait R, Watchurst C, Chua K-C, Loftus V, Young T, Lamping DL, Knapp M, Howard R, Banerjee S. Development of DEMQOL-U and DEMQOL-Proxy-U. Health Technology Assessment. in press.
    1. Cummings JL, Mega M, Gray K, Rosenberg-Thompson S, Carusi DA, Gornbein J. The Neuropsychiatric Inventory: Comprehensive assessment of psychopathology in dementia. Neurology. 1994;44:2308–2314. doi: 10.1212/WNL.44.12.2308.
    1. Cummings JL. The neuropsychiatric inventory: assessing psychopathology in dementia patients. Neurology. 1997;48(suppl 6):S10–S16.
    1. Bucks RS, Ashworth DL, Wilcock GK, Siegfried K. Assessment of Activities of Daily Living in Dementia: Development of the Bristol Activities of Daily Living Scale. Age and ageing. 1995;25:113–120.
    1. Byrne LMT, Wilson PMA, Bucks RS, Hughes AO, Wilcock GK. The sensitivity to change over time of the Bristol activities of daily living scale in Alzheimer’s disease. Int J Geriatr Psychiatry. 2000;15:656–661. doi: 10.1002/1099-1166(200007)15:7<656::AID-GPS163>;2-Q.
    1. Sheikh JI, Yesavage JA. In: Clinical Gerontology: A guide to Assessment and Intervention. Volume 5. Brink TL, editor. New York: The Haworth Press, Inc; 1986. Geriatric Depression Scale (GDS) Recent evidence and development of a shorter version; pp. 165–173.
    1. Lach HW, Chang YP, Edwards D. Can older adults with dementia accurately report depression using brief forms? Reliability and validity of the Geriatric Scale. J Gerontol Nurs. 2010;36:30–37.
    1. Spruytte N, van Audenhove C, Lammertyn F, Storms G. The quality of the caregiving relationship in informal care for older adults with dementia and chronic psychiatric patients. Psychol Psychother. 2002;75:295–311. doi: 10.1348/147608302320365208.
    1. Ware JE Jr, Kosinki M, Keller S. A 12 item short form health survey. Construction of scales and preliminary tests of reliability and validity. Med Care. 1996;34:220–223. doi: 10.1097/00005650-199603000-00003.
    1. Zigmond AS, Snaith RP. The Hospital Anxiety and Depression Scale. Acta Psychiatr Scand. 1983;67:361–70. doi: 10.1111/j.1600-0447.1983.tb09716.x.
    1. Mykletun A, Stordal E, Dahl AA. Hospital Anxiety and Depression (HAD) scale: factor structure, item analyses and internal consistency in a large population. Br J Psychiatry. 2001;179:540–544. doi: 10.1192/bjp.179.6.540.
    1. Group EQ. EuroQoL: A new facility for the measurement of health related quality of life. Health Policy. 1990;16:199–208.
    1. Pickard AS, Wilke CT, Hsiang-Wen L, Lloyd A. Health Utilities Using the EQ 5D in Studies of Cancer. Pharmacoeconomics. 2007;25:365–384. doi: 10.2165/00019053-200725050-00002.
    1. Dyer MT, Goldsmith KA, Sharples LS, Buxton MJ. A review of health utilities using the EQ-5D in studies of cardiovascular disease. Health Qual Life Outcomes. 2010;8:13. doi: 10.1186/1477-7525-8-13.
    1. Wagnild G, Young H. Development and psychometric evaluation of the resilience scale. J Nurs Meas. 1993;1:165–177.
    1. Wagnild GM. The Resilience Scale user’s Guide for the US English version of the Resilience Scale and the 14-item Resilience Scale (RS-14) Montana: The Resilience Center; 2009.
    1. Department of Health. Reference Costs. London: Reference Costs; 2011. pp. 10–2009.
    1. Curtis L. Unit Costs of Health and Social Care. University of Kent: Personal Social Services Research Unit; 2011.
    1. Koopmanschap MA, van Exel JNA, van der Berg B, Brouwer WBF. An Overview of Methods and Applications to Value Informal Care in Economic Evaluations of Healthcare. Pharmacoeconomics. 2008;25:365–384.
    1. Pritchard C, Sculpher M. Productivity Costs. London: Principles and Practice in Economic Evaluation. Office of Health Economics; 2000.
    1. Smith RD, Richardson J. Can we estimate the ‘social’ value of a QALY?: Four core issues to resolve. Health Policy. 2005;74:77–84. doi: 10.1016/j.healthpol.2004.12.009.
    1. Rawlins MD, Culyer AJ. National Institute for Clinical Excellence and its value judgements. BMJ. 2005;74:77–84.
    1. Fenwick E, O’Brien BJ, Briggs A. Cost-effectiveness acceptability curves-facts, fallacies and frequently asked questions. Health Econ. 2004;13:405–415. doi: 10.1002/hec.903.
    1. National Audit Office. Improving services and support for people with Dementia. .

Source: PubMed

Sponsorer og samarbejdspartnere

Medicinske tilstande

Narkotikainterventioner

3
Abonner